Louise Wilson-English

Inhibrx provides clinical update on ozekibart in late line colorectal cancer

US$ 8.5 million investment in malaria and other R&D projects planned among pharma giants

Positive phase 1 data for RAG-17 in amyotrophic lateral sclerosis patients with mutations in the superoxide dismutase 1 gene

New non-compromise early-phase progression accelerator launched

AstraZeneca to seek accelerated approval of Ultomirisin in immunoglobulin A nephropathy on phase 3 data

Tenvie doses first subject in phase 1 TNV108 trial for peripheral neuropathies

Roche reports phase 3 study results for myelin oligodendrocyte glycoprotein antibody-associated disease

Interphex Week Tokyo 2026 organises show floor around manufacturing, packaging, inspection and digital production technologies

Bio-Rad launches PTC Harmony 96 and PTC Harmony Deepwell thermal cyclers

Evotec announces chief financial officer transition